Anti-Ageing & Longevity Panel

Advanced anti-ageing and longevity assessment combining comprehensive biomarker testing, body composition analysis, brain function screening, lung function, and optional advanced imaging to establish a complete biological age baseline and personalised longevity action plan.

Fullerton Health's Anti-Ageing and Longevity Panel sits at the premium end of its Fuller Life executive screening range, combining the depth of the Sapphire and Platinum plans with a longevity medicine lens. This integrated assessment goes beyond conventional disease screening to evaluate the biological mechanisms that determine how quickly or slowly an individual is ageing — providing both a baseline and a roadmap for extending healthspan. The panel begins with a full physical examination and physician consultation to establish baseline health status and understand the patient's health history, lifestyle, and longevity goals. Blood investigations cover all standard screening markers plus extended longevity-relevant biomarkers: inflammatory markers (hsCRP, homocysteine), metabolic and insulin resistance indicators (fasting insulin, HOMA-IR, adiponectin), hormonal status (testosterone or oestrogen and progesterone, DHEA-S, IGF-1), and nutrient markers (vitamin D, vitamin B12, ferritin). Body composition analysis using bioelectrical impedance provides a detailed breakdown of fat mass, lean mass, visceral fat, body water, and bone mass — key indicators of metabolic health and sarcopenia risk, both of which are strongly predictive of all-cause mortality and quality of life in later decades. Digital brain function screening at the Sapphire level and above assesses cognitive processing speed, working memory, and executive function — providing an early signal of neurological vulnerability that can inform targeted neuroprotective interventions. Spirometry (lung function testing) characterises respiratory reserve, a robust independent predictor of longevity. At the Platinum tier, the assessment incorporates advanced cardiovascular imaging via CT cardiac calcium scoring — one of the strongest available predictors of future heart attack risk, capable of identifying subclinical atherosclerosis years before symptoms appear. Bone density assessment with vitamin D evaluation addresses osteoporosis risk, which is particularly relevant for perimenopausal women and sedentary men over 50. All results are synthesised into a comprehensive medical report reviewed in a physician consultation, where biological age relative to chronological age is contextualised, priority intervention areas are identified, and a personalised longevity action plan is developed covering nutrition, exercise, supplementation, and any clinical follow-up required.